About Rhaeos
Rhaeos is a company based in Evanston (United States) founded in 2018 by Amit Ayer, Siddharth Krishnan, and John Rogers. It operates as a HealthTech. Rhaeos has raised $12.8 million across 9 funding rounds from investors including NIH, HHS and Northwestern University. The company has 10 employees as of December 31, 2022. Rhaeos offers products and services including FlowSense. Rhaeos operates in a competitive market with competitors including Ceribell, Kernel, NeuroKaire, Seer and Therma, among others.
- Headquarter Evanston, United States
- Employees 10 as on 31 Dec, 2022
- Founders Amit Ayer, Siddharth Krishnan, John Rogers
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rhaeos, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.8 M (USD)
in 9 rounds
-
Latest Funding Round
$306.52 K (USD), Grant
Sep 15, 2024
-
Investors
NIH
& 14 more
-
Employee Count
10
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rhaeos
Rhaeos offers a comprehensive portfolio of products and services, including FlowSense. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
FlowSense assesses hydrocephalus shunt flow in minutes.
Unlock access to complete
Unlock access to complete
Funding Insights of Rhaeos
Rhaeos has successfully raised a total of $12.8M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $306.52 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Grant — $306,522
-
First Round
First Round
(01 Jan 2020)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Grant - Rhaeos | Valuation |
investors |
|
| Oct, 2023 | Amount | Grant - Rhaeos | Valuation |
investors |
|
| Feb, 2023 | Amount | Series A - Rhaeos | Valuation | Artistic Ventures , Steele Foundation for Hope |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rhaeos
Rhaeos has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Northwestern University. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Creative Ventures is focused on deep tech venture investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rhaeos
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rhaeos
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rhaeos Comparisons
Competitors of Rhaeos
Rhaeos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceribell, Kernel, NeuroKaire, Seer and Therma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Portable EEG devices for point-of-care seizure diagnosis are provided.
|
|
| domain | founded_year | HQ Location |
Multimodal brain measurement technology is developed for neuromedicine applications.
|
|
| domain | founded_year | HQ Location |
Platform offering personalized treatment for psychiatric and neurological conditions
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| domain | founded_year | HQ Location |
Solutions for temperature, humidity, and energy monitoring are provided.
|
|
| domain | founded_year | HQ Location |
Wearable devices and app are provided for mental disorder support.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rhaeos
Frequently Asked Questions about Rhaeos
When was Rhaeos founded?
Rhaeos was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Rhaeos located?
Rhaeos is headquartered in Evanston, United States. It is registered at Evanston, Illinois, United States.
Who is the current CEO of Rhaeos?
Anna Lisa Somera is the current CEO of Rhaeos.
Is Rhaeos a funded company?
Rhaeos is a funded company, having raised a total of $12.8M across 9 funding rounds to date. The company's 1st funding round was a Series A of $10.5M, raised on Jan 01, 2020.
How many employees does Rhaeos have?
As of Dec 31, 2022, the latest employee count at Rhaeos is 10.
What does Rhaeos do?
Rhaeos is engaged in the development of non-invasive, wireless, and wearable medical devices for hydrocephalus patients. Their primary product, FlowSense, is designed to assess shunt flow in minutes, addressing challenges in detecting shunt malfunctions. The company operates within the healthcare sector, targeting solutions for neurological conditions. Collaborations with various partners and participation in clinical events are maintained to advance their investigational devices. Their technology aims to reduce readmission rates and emergency department visits for hydrocephalus patients in the United States.
Who are the top competitors of Rhaeos?
Rhaeos's top competitors include Ceribell, CND Life Sciences and Therma.
What products or services does Rhaeos offer?
Rhaeos offers FlowSense.
Who are Rhaeos's investors?
Rhaeos has 15 investors. Key investors include NIH, HHS, Northwestern University, Gener8tor, and Artistic Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.